Skip to main content
FinSpry Logo
FinSpry
NGEN logo
NGEN
(NASDAQ)
NervGen Pharma Corp.
$2.19-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NervGen Pharma (NGEN) Stock Price & Financial Analysis

NervGen Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.16 - $2.35
52-Week High$6.30
52-Week Low$1.58
Open$2.32
Volume712.94K
Average Volume (3M)531.82K
Market Cap168.53M
Shares Outstanding72.33M
Price to Book (P/B)66.77
EV/EBITDA-28.00
50-Day MA$1.87
200-Day MA$3.38
52-Week Change-17.98%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NervGen Pharma

What is the current stock price for NGEN?

As of the latest trading session, NGEN stock trades at $2.19. The 52-week range is $1.58–$6.30, with a day range of $2.16–$2.35.

What is the P/E ratio for NGEN?

The P/E ratio (Price-to-Earnings) for NGEN is shown in the Key Statistics section. This valuation metric helps compare NervGen Pharma Corp. to industry peers.

Does NGEN pay dividends?

NervGen Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NGEN?

Based on 3 analysts, the consensus for NGEN is Buy.

What is the market cap of NGEN?

NervGen Pharma's market capitalization is $158.4M, classifying it as a micro-cap company. NervGen Pharma operates in the Healthcare sector within the Biotechnology industry.